Skip to main content

Find Clinical Trials

Home
Conditions
Gastrointestinal Neoplasms

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

9,338 public trials 2,094 recruiting studies

Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Completed

Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer

NCT00128622

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +33 more
Locations: Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington D.C., District of Columbia, United States

Duke Comprehensive Cancer Center Durham, North Carolina, United States

View Trial Details

Completed

Study of Intravenous Aflibercept in Combination With FOLFIRI in Japanese Patients With Metastatic Colorectal Cancer

NCT00921661

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +12 more
Locations: Sanofi-Aventis Administrative Office Tokyo, Japan

View Trial Details

Completed

PeerScope B System™ Clinical Protocol

NCT01483040

Conditions: Colon Adenomas, Colon Cancer, Colon Diseases, +17 more
Locations: Elisha Medical Center Haifa, Israel

View Trial Details

Completed

RCT With Adjuvant Mistletoe Treatment in Gastric Cancer Patients

NCT01401075

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +6 more
Locations: ASAN Medical Center Seoul, South Korea

View Trial Details

Completed

Patient Navigator Project

NCT00375024

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +14 more
Locations: H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

View Trial Details

Completed

Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal Cancer

NCT00569790

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations: Hokkaido University Hospital (Hokkaido Gastrointestinal Cancer Study Group) Sapporo, Hokkaido, Japan

View Trial Details

Completed

Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer

NCT00284258

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations: Saku Central Hospital Saku, Nagano, Japan

View Trial Details

Completed

Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC)

NCT00569699

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations: Osaka Medical College Hospital Takatsuki, Osaka, Japan

View Trial Details

Completed

Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer

NCT00569335

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +9 more
Locations: National Cancer Center Hospital Tsukiji, Chuo-ku, Tokyo, Japan

View Trial Details

Completed

A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer

NCT00478634

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Carcinoma, +12 more
Locations: Highlands Oncology Group Fayetteville, Arkansas, United States

Comprehensive nBlood and Cancer Care Bakersfield, California, United States

UCSD - Moores Cancer Center La Jolla, California, United States

Comprehensive Cancer Care Los Angeles, California, United States

View all 16 locations

View Trial Details